CA2785262A1 - Nutritional compositions and methods for optimizing dietary acid-base potential - Google Patents

Nutritional compositions and methods for optimizing dietary acid-base potential Download PDF

Info

Publication number
CA2785262A1
CA2785262A1 CA2785262A CA2785262A CA2785262A1 CA 2785262 A1 CA2785262 A1 CA 2785262A1 CA 2785262 A CA2785262 A CA 2785262A CA 2785262 A CA2785262 A CA 2785262A CA 2785262 A1 CA2785262 A1 CA 2785262A1
Authority
CA
Canada
Prior art keywords
protein
acid
nutritional
content
nutritional composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2785262A
Other languages
English (en)
French (fr)
Inventor
Kevin Burke Miller
Zamzam Kabiry Roughead
Jennifer Rae Mager
Douglas Richard Bolster
Norman Alan Greenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Publication of CA2785262A1 publication Critical patent/CA2785262A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mathematical Optimization (AREA)
  • Immunology (AREA)
  • Software Systems (AREA)
  • Databases & Information Systems (AREA)
  • Algebra (AREA)
  • Pure & Applied Mathematics (AREA)
CA2785262A 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential Abandoned CA2785262A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US28892809P 2009-12-22 2009-12-22
US61/288,928 2009-12-22
US29668810P 2010-01-20 2010-01-20
US61/296,688 2010-01-20
US201061424070P 2010-12-17 2010-12-17
US61/424,070 2010-12-17
PCT/US2010/061444 WO2011087769A2 (en) 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential

Publications (1)

Publication Number Publication Date
CA2785262A1 true CA2785262A1 (en) 2011-07-21

Family

ID=44304885

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2785262A Abandoned CA2785262A1 (en) 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential

Country Status (13)

Country Link
US (1) US20130129838A1 (enEXAMPLES)
EP (1) EP2516007A2 (enEXAMPLES)
JP (1) JP2013514812A (enEXAMPLES)
CN (1) CN102753043A (enEXAMPLES)
AU (1) AU2010341566A1 (enEXAMPLES)
BR (1) BR112012018321A2 (enEXAMPLES)
CA (1) CA2785262A1 (enEXAMPLES)
IN (1) IN2012DN05279A (enEXAMPLES)
MX (1) MX2012007300A (enEXAMPLES)
PH (1) PH12012501150A1 (enEXAMPLES)
RU (1) RU2012131125A (enEXAMPLES)
SG (1) SG181619A1 (enEXAMPLES)
WO (1) WO2011087769A2 (enEXAMPLES)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150150898A1 (en) * 2012-06-11 2015-06-04 Nu Science Laboratories, Inc. Nutritional products and methods of improving exercise performance and reducing exercise induced impairment of immune function
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
CN104780786A (zh) * 2012-09-21 2015-07-15 雅培制药有限公司 包括β-羟基-β-甲基丁酸钙、蛋白质和低水平的电解质的营养组合物
JP6276286B2 (ja) * 2012-12-14 2018-02-07 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルのための老化防止の食品
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
AU2013404985B2 (en) * 2013-11-05 2017-06-15 Hill's Pet Nutrition, Inc. Methods and compositions for improving kidney function
CA2981045A1 (en) * 2015-03-26 2016-09-29 Cambrooke Therapeutics, Inc. Aqueous ketogenic compositions
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
IT202000008203A1 (it) * 2020-04-17 2021-10-17 D M F Dietetic Metabolic Food S R L Composizione nutrizionale per il trattamento delle malattie metaboliche
WO2025181327A1 (en) 2024-03-01 2025-09-04 Aarhus Universitet Quantification of renal acid-base excretion in people with short bowel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002204A1 (de) * 1990-01-26 1991-08-01 Westfalen Milchwerke Diaetetisches nahrungsmittel fuer patienten mit niereninsuffizienz
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
JP2000264844A (ja) * 1999-01-11 2000-09-26 Otsuka Pharmaceut Factory Inc 腎疾患患者用栄養組成物
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US20090137459A1 (en) * 2005-11-21 2009-05-28 Katry Inversiones, S.L. Food Product for Enteral or Oral Nutrition

Also Published As

Publication number Publication date
BR112012018321A2 (pt) 2019-09-24
CN102753043A (zh) 2012-10-24
PH12012501150A1 (en) 2012-10-22
AU2010341566A1 (en) 2012-07-12
EP2516007A2 (en) 2012-10-31
WO2011087769A3 (en) 2011-10-27
JP2013514812A (ja) 2013-05-02
WO2011087769A2 (en) 2011-07-21
MX2012007300A (es) 2012-07-04
SG181619A1 (en) 2012-07-30
RU2012131125A (ru) 2014-01-27
US20130129838A1 (en) 2013-05-23
IN2012DN05279A (enEXAMPLES) 2015-08-07

Similar Documents

Publication Publication Date Title
US20130129838A1 (en) Nutritional compositions and methods for optimizing dietary acid-base potential
Gleeson Dosing and efficacy of glutamine supplementation in human exercise and sport training
ES2605453T3 (es) Suplemento de la dieta maternal
JP6852980B2 (ja) 低カロリー高タンパク質の栄養組成物及び該栄養組成物を用いる方法
NO326348B1 (no) Naeringssammensetning, fremgangsmate for fremstilling derav og anvendelse av sammensetningen.
US20240122935A1 (en) Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring
Tanner et al. Nutrient intake in lysinuric protein intolerance
MacDonald et al. Protein substitutes for PKU: what's new?
Lamport et al. Effects of nutrition supplementation on osmolality of expressed human milk
van den Berg et al. The effect of glutamine‐enriched enteral nutrition on intestinal permeability in very‐low‐birth‐weight infants: a randomized controlled trial
US20180085384A1 (en) Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children
US10980786B2 (en) Maternal vitamin B6 administration for the prevention of increased adiposity, overweight or obesity in the offspring
CN116584544A (zh) 一种儿童成长羊奶粉配方及其制备工艺
Fatima et al. Nutritional supplements and their use in the treatment of malnutrition in developing countries
EP4408198A1 (en) Compositions for use
US20220096524A1 (en) Methods of promoting healthy catch-up growth
US20230110977A1 (en) Methods of improving bone health
Rondón Nutritional Factors Affecting Magnesium Bioavailability: A Narrative Review: LJ Rondon
Barry Weinberger et al. Effects of Nutrition Supplementation on Osmolality of Expressed Human Milk
EP4408200A1 (en) Compositions for use
CN120225074A (zh) 肌肉肌醇和预防加速生长
Taylor et al. Intestinal Development and Permeability: Role in Nutrition of Preterm Infants
Rodríguez Nutrition Support of the Septic Patient

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20151222